21 August 2025

Rheumatoid Arthritis

JAKis linked to Hep B reactivation risk in RA patients

21 August 2025

Political Technology TheHill Workforce

Doctors may have to share one-on-one referral letters

21 August 2025

ACR Guidelines

Global experts set framework for VEXAS care

21 August 2025

The Back Page

Made-up body parts? Tech bots must be dreaming

21 August 2025

Comment Mental Health

The therapeutic tool of kindness

21 August 2025

FDA Fibromyalgia

FDA approves first new fibromyalgia therapy in 16 years

21 August 2025

Clinical research Digital Health Policy

The promise of real-world data: what are we missing?

21 August 2025

Clinical research Pain

No solid evidence ketamine eases chronic pain: researchers

21 August 2025

Paediatrics Psoriasis

Oral psoriasis therapy holds up in kids

7 August 2025

Cannabis Telehealth TGA

TGA to launch medicinal cannabis regulation consultation

7 August 2025

Back Page

Robots coming for public health too

7 August 2025

AI Digital Health TGA Uncategorized

Vendors want AI scribe clarity, welcome TGA review

7 August 2025

General Practice RACGP

Third Degree: the pharmacopoeia without the ‘pharma’

7 August 2025

Hidradenitis Suppurativa Mental Health

HS patients face elevated mental health risk

7 August 2025

Biosimilars PBAC

Biosimilars denosumab and tocilizumab head to PBAC

7 August 2025

Clinical research Rheumatoid Arthritis

Placebo response higher in RA trials from lower-income countries